Osamu Moro

Title: Osamu Moro: Innovator in Vasodilating Action Research

Introduction

Osamu Moro is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmacology, particularly in the study of vasodilating actions. With a total of 2 patents, his work has implications for understanding and developing treatments related to vascular health.

Latest Patents

Moro's latest patents include a method for screening agonists or antagonists of the maxadilan receptor, which plays a crucial role in vasodilating action. This method utilizes a receptor of maxadilan, compounds that specifically bind to this receptor, and a tissue preparation containing the receptor. The compounds he has identified are variants of maxadilan derived from the salivary glands of the sand fly. Additionally, he has developed peptides that have a specific affinity to pituitary adenylate cyclase activating polypeptide (PACAP) receptors. Notably, the peptides MAX and NSP act as agonists to PACAP type 1 receptors, while M65 functions as an antagonist.

Career Highlights

Throughout his career, Osamu Moro has worked with prominent organizations, including Shiseido Company, Limited and The General Hospital Corporation. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Moro has collaborated with notable colleagues such as Kawori Wakita and Manami Ohnuma. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Osamu Moro's innovative work in the field of pharmacology, particularly regarding vasodilating actions, showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving health outcomes through research and innovation.